Search research articles
Contact Us
Filters
Showing results (721-730 of 760) with videos related to
Page
of 76
Sort By:
The New England Journal of Medicine
|
May 1, 2008
Multiple genetic loci for bone mineral density and fractures
Unnur Styrkarsdottir, Bjarni V Halldorsson, Solveig Gretarsdottir, et al.
Cell Stem Cell
|
December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy
Claudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Journal of the Endocrine Society
|
September 22, 2025
Intravenous Arginine Stimulates Glucagon Secretion More Than Equimolar Alanine, Leucine, Glutamine, and Proline in Humans
Malte Palm Suppli, Astrid Høgedal, Jonatan Ising Bagger, et al.
The Journal of Biological Chemistry
|
March 24, 2025
Complex G-protein signaling of the adhesion GPCR, ADGRA3
Sofie M Bagger, Hannes Schihada, Anna L S Walser, et al.
BMC Nephrology
|
June 27, 2022
First-year mortality in incident dialysis patients: results of the Peridialysis study
James Heaf, Maija Heiro, Aivars Petersons, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 15, 2021
Transcriptional characterization of human megakaryocyte polyploidization and lineage commitment
Fizzah A Choudry, Frederik O Bagger, Iain C Macaulay, et al.
Leukemia
|
January 11, 2023
The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes
Mette Louise Trempenau, Mikkel Bruhn Schuster, Sachin Pundhir, et al.
Elife
|
April 25, 2025
Changes in local mineral homeostasis facilitate the formation of benign and malignant testicular microcalcifications
Ida Marie Boisen, Nadia Krarup Knudsen, John E Nielsen, et al.
Diabetes
|
December 17, 2015
Evidence of Extrapancreatic Glucagon Secretion in Man
Asger Lund, Jonatan I Bagger, Nicolai J Wewer Albrechtsen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years
Stephen L Hauser, Anne H Cross, Kevin Winthrop, et al.
Page
of 76
Search research articles
Search
Showing results (721-730 of 760) with videos related to
Sort By:
Page
of 76
The New England Journal of Medicine
|
May 1, 2008
Multiple genetic loci for bone mineral density and fractures
Unnur Styrkarsdottir, Bjarni V Halldorsson, Solveig Gretarsdottir, et al.
Cell Stem Cell
|
December 7, 2014
Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy
Claudia Bruedigam, Frederik O Bagger, Florian H Heidel, et al.
Journal of the Endocrine Society
|
September 22, 2025
Intravenous Arginine Stimulates Glucagon Secretion More Than Equimolar Alanine, Leucine, Glutamine, and Proline in Humans
Malte Palm Suppli, Astrid Høgedal, Jonatan Ising Bagger, et al.
The Journal of Biological Chemistry
|
March 24, 2025
Complex G-protein signaling of the adhesion GPCR, ADGRA3
Sofie M Bagger, Hannes Schihada, Anna L S Walser, et al.
BMC Nephrology
|
June 27, 2022
First-year mortality in incident dialysis patients: results of the Peridialysis study
James Heaf, Maija Heiro, Aivars Petersons, et al.
Journal of Thrombosis and Haemostasis : JTH
|
February 15, 2021
Transcriptional characterization of human megakaryocyte polyploidization and lineage commitment
Fizzah A Choudry, Frederik O Bagger, Iain C Macaulay, et al.
Leukemia
|
January 11, 2023
The histone demethylase KDM5C functions as a tumor suppressor in AML by repression of bivalently marked immature genes
Mette Louise Trempenau, Mikkel Bruhn Schuster, Sachin Pundhir, et al.
Elife
|
April 25, 2025
Changes in local mineral homeostasis facilitate the formation of benign and malignant testicular microcalcifications
Ida Marie Boisen, Nadia Krarup Knudsen, John E Nielsen, et al.
Diabetes
|
December 17, 2015
Evidence of Extrapancreatic Glucagon Secretion in Man
Asger Lund, Jonatan I Bagger, Nicolai J Wewer Albrechtsen, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
March 1, 2022
Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years
Stephen L Hauser, Anne H Cross, Kevin Winthrop, et al.
Page
of 76